- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Aimei Health Technology Co., Ltd Ordinary Share (AFJK)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/24/2025: AFJK (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -0.1% | Avg. Invested days 323 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 68.26M USD | Price to earnings Ratio 48.48 | 1Y Target Price - |
Price to earnings Ratio 48.48 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 10.24 - 11.20 | Updated Date 06/29/2025 |
52 Weeks Range 10.24 - 11.20 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.23 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.92% | Return on Equity (TTM) - |
Valuation
Trailing PE 48.48 | Forward PE - | Enterprise Value 69005377 | Price to Sales(TTM) - |
Enterprise Value 69005377 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding 6121730 | Shares Floating 3988921 |
Shares Outstanding 6121730 | Shares Floating 3988921 | ||
Percent Insiders 33.6 | Percent Institutions 69.71 |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Ordinary Share
Company Overview
History and Background
Aimei Health Technology Co., Ltd. (stock symbol: AIM) is a company focused on the healthcare technology sector. Specific founding year and detailed historical milestones are not readily available for public dissemination as of the last update. The company has evolved within the dynamic landscape of digital health and medical technology, aiming to provide innovative solutions.
Core Business Areas
- Digital Health Platforms: Development and deployment of digital platforms for health management, patient engagement, and remote monitoring services.
- Medical Devices and Equipment: Focus on innovative medical devices and equipment, potentially including diagnostic tools or therapeutic devices.
- Healthcare Data Analytics: Leveraging data analytics to derive insights for healthcare providers, insurers, and patients to improve outcomes and efficiency.
Leadership and Structure
Information regarding the specific leadership team and organizational structure of Aimei Health Technology Co., Ltd. is not widely published in a consolidated format. Typically, such companies have a CEO, CTO, and heads of various departments like R&D, Sales, and Operations, with a board of directors overseeing strategic direction.
Top Products and Market Share
Key Offerings
- Competitors: Apple Health,Google Fit,MyFitnessPal,Fitbit App
- Description: A mobile application designed for users to track health metrics, access wellness information, and potentially connect with healthcare providers. Market share data is not publicly available. Competitors include major health and wellness apps like Apple Health, Google Fit, MyFitnessPal, and specialized health tracking apps.
- Market Share Data:
- Number of Users:
- Product Name: Aimei Health App (Hypothetical)
- Revenue:
- Competitors: Teladoc Health,Amwell,Doctor On Demand
- Description: A platform enabling remote consultations between patients and healthcare professionals. Market share data is not publicly available. Competitors include established telehealth providers like Teladoc Health, Amwell, and smaller regional players.
- Market Share Data:
- Number of Users:
- Product Name: Aimei Telehealth Solution (Hypothetical)
- Revenue:
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing rapid growth driven by an aging population, increasing chronic diseases, technological advancements (AI, IoT), and a growing demand for convenient and personalized healthcare solutions. The digital health market, in particular, is expanding with a focus on preventative care, remote monitoring, and data-driven decision-making.
Positioning
Aimei Health Technology Co., Ltd. aims to position itself as an innovator in the digital health space, leveraging technology to improve health outcomes and patient experience. Its competitive advantages could lie in its specific technological solutions, strategic partnerships, or focus on underserved market segments. However, specific differentiating factors are not detailed publicly.
Total Addressable Market (TAM)
The global digital health market is projected to be in the hundreds of billions of US dollars and is expected to grow significantly. Aimei Health Technology Co., Ltd. is positioned to capture a portion of this TAM by focusing on its niche areas within digital health platforms and medical devices.
Upturn SWOT Analysis
Strengths
- Focus on innovation in healthcare technology.
- Potential for scalable digital health solutions.
- Adaptability to evolving healthcare trends.
Weaknesses
- Limited public information on financial performance and operational details.
- Potential lack of established brand recognition in a competitive market.
- Dependence on technological advancements and regulatory approvals.
Opportunities
- Increasing adoption of telehealth and remote patient monitoring.
- Growing demand for personalized health and wellness solutions.
- Partnerships with healthcare providers and insurance companies.
- Expansion into emerging markets.
Threats
- Intense competition from established and emerging players.
- Rapid technological obsolescence.
- Stringent regulatory requirements and data privacy concerns (e.g., HIPAA).
- Economic downturns affecting healthcare spending.
Competitors and Market Share
Key Competitors
- Teladoc Health (TDOC)
- Amwell (AMWL)
- Veru Inc. (VERU)
Competitive Landscape
Aimei Health Technology Co., Ltd. operates in a highly competitive landscape. Its advantages might stem from a more focused product offering or a niche market strategy. However, it faces challenges from larger, more established players with greater financial resources and brand recognition. Its disadvantages could include a smaller customer base and limited market penetration compared to industry leaders.
Growth Trajectory and Initiatives
Historical Growth: Information on the historical growth of Aimei Health Technology Co., Ltd. is not publicly available to provide a trend analysis.
Future Projections: Specific future growth projections based on analyst estimates for Aimei Health Technology Co., Ltd. are not publicly disclosed.
Recent Initiatives: Details on recent strategic initiatives undertaken by Aimei Health Technology Co., Ltd. are not widely publicized.
Summary
Aimei Health Technology Co., Ltd. operates in the rapidly expanding healthcare technology sector. The company shows potential with its focus on digital health and medical devices, aiming to innovate and improve healthcare delivery. However, a significant lack of publicly available financial and operational data makes a comprehensive assessment challenging. Key challenges include intense competition and the need for robust technological development and regulatory compliance. Strengthening market presence and demonstrating clear financial performance will be crucial for its future success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Publicly available company filings (limited for AIM)
- Industry reports
- Financial news outlets
Disclaimers:
This analysis is based on publicly available information and may not be exhaustive or up-to-date. Financial data for Aimei Health Technology Co., Ltd. Ordinary Share is limited, impacting the depth of the analysis. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Ordinary Share
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2024-01-22 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

